Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |